# § 412.170   Definitions for the Hospital-Acquired Condition Reduction Program.

As used in this section and § 412.172, the following definitions apply:


*Applicable hospital* is a hospital described in section 1886(d)(1)(B) of the Act (including a hospital in Maryland that is paid under the waiver under section 1814(b)(3) of the Act and that, absent the waiver specified by section 1814(b)(3) of the Act, would have been paid under the hospital inpatient prospective payment system) as long as the hospital meets the criteria specified under § 412.172(e).


*Applicable period* is, unless otherwise specified by the Secretary, with respect to a fiscal year, the 2-year period (specified by the Secretary) from which data are collected in order to calculate the total hospital-acquired condition score under the Hospital-Acquired Condition Reduction Program.


(1) The applicable period for FY 2022—


(i) For the CMS PSI 90 measure, is the 24-month period from July 1, 2018 through June 30, 2020; and


(ii) For the CDC NHSN HAI measures, is the 24-month period from January 1, 2019 through December 31, 2020.


(2) Beginning with the FY 2023 program year, the applicable period is the 24-month period advanced by 1-year from the prior fiscal year's period from which data are collected in order to calculate the total hospital-acquired condition score under the Hospital-Acquired Condition Reduction Program, unless otherwise specified by the Secretary.


*CDC NHSN HAI* stands for Centers for Disease Control and Prevention National Healthcare Safety Network healthcare-associated infection measures.


*CMS PSI 90* stands for Patient Safety and Adverse Events Composite for Selected Indicators (modified version of PSI 90).


*Hospital-acquired condition* is a condition as described in section 1886(d)(4)(D)(iv) of the Act and any other condition determined appropriate by the Secretary that an individual acquires during a stay in an applicable hospital, as determined by the Secretary.



---

[N] [78 FR 50967, Aug. 19, 2013, as amended at 81 FR 57268, Aug. 22, 2016; 85 FR 59022, Sept. 18, 2020]




